Skip to content

Relieving the Exterior Syndrome and Heat-reducing Therapy to Treat the Fever Caused by Viral Upper Respiratory Tract Infection in TCM Emergency Care

Relieving the Exterior Syndrome and Heat-reducing Therapy to Treat the Fever Caused by Viral Upper Respiratory Tract Infection in TCM Emergency Care

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-10001004
Enrollment
Unknown
Registered
2010-08-25
Start date
2010-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

viral upper respiratory tract infection

Interventions

1:Shanggan granules (Temparature between 37.2 ~ 39.0 degree: 1 piece Po. Bid
T >=39.0: give one more piece) + placebo for Bufferin Cold tablets (Day: 1 tablet Po. Bid
Night: 1 tablet Po. Qn. Medication interval > 6 hours)
2:Low-dosage Shanggan granules (Temparature between 37.2 to 39.0 degree: 1 piece Po. Bid
3:Bufferin Cold tablets (Day: 1 tablet Po. Bid
Night: 1 tablet Po. Qn. Medication interval > 6 hours) + Low-dosage Shanggan granules (Temparature between 37.2 and 39.0 degree C: 1 piece Po. Bid
T >=39.0: give one more piece)

Sponsors

The Hospital of Traditional Chinese Medicine of Jiangsu Province, Nanjing University of TCM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. With the diagnosis criteria of fever caused by viral upper respiratory tract infection and exogenous high fever; 2. Aged between 18 and 70 years old; 3. Acute onset of disease and duration of disease within 48 hours; 4. Temperature>=38.0 degree C; 5. WBC between 10.00*10^9/L to 3.5*10^9/L and neutrophil count <=85%; 6. Sign the informed consents based on the guideline of GCP.

Exclusion criteria

Exclusion criteria: 1. Fever caused by lower respiratory tract infection or infection of other respiratory, gastrointestinal, urological and hematological systems; 2. Pregnant or breast-feeding female; 3. With primary cardio-vascular diseases, liver diseases, renal diseases, hematological diseases, lung diseases and other severe disorders.

Design outcomes

Primary

MeasureTime frame
Body temperature, clinical symptoms, physical sign;

Countries

China

Contacts

Public ContactZhaoqing Xi
xizhaoqing49@yahoo.com+86 13851775746

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026